This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.
Print Document
Reports
Document and Entity Information
Statements
Consolidated balance sheets
Consolidated balance sheets (Parenthetical)
Consolidated statements of operations and comprehensive loss
Consolidated statements of stockholders' equity
Consolidated statements of cash flows
Reports
Pay vs Performance Disclosure
Insider Trading Arrangements
Nature of the Business
Summary of Significant Accounting Policies and Recent Accounting Pronouncements
Fair Value Measurements
Marketable Securities
Accrued and Other Current Liabilities
Commitments and Contingencies
License and Collaboration Agreement with Acadia Pharmaceuticals Inc
Equity Incentive Plans
Net Loss Per Share
Income Taxes
Subsequent Events
Accounting Policies
Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)
Tables
Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)
Fair Value Measurements (Tables)
Marketable Securities (Tables)
Accrued and Other Current Liabilities (Tables)
Commitments and Contingencies (Tables)
Equity Incentive Plans (Tables)
Net Loss Per Share (Tables)
Details
Nature of the Business - Additional Information (Details)
Summary of Significant Accounting Policies and Recent Accounting Pronouncements - Schedule of Cash and Cash Equivalents and Restricted Cash (Details)
Fair Value Measurements - Schedule of Financial Assets Measured at Fair Value on Recurring Basis and Level of Fair Value Hierarchy Utilized (Details)
Fair Value Measurements - Additional Information (Details)
Marketable Securities - Summary of Marketable securities (Details)
Marketable Securities - Additional Information (Details)
Accrued and Other Current Liabilities - Schedule of Accrued and Other Current Liabilities (Details)
Commitments and Contingencies - Additional Information (Details)
Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-Cancellable Leases (Details)
Commitments and Contingencies - Summary of Lease Balances (Details)
Commitments and Contingencies - Summary of Weighted Average Remaining Lease Term and Weighted Average Discount Rate of Operating Leases (Details)
License and collaboration agreement with Acadia Pharmaceuticals Inc - Additional Information (Details)
Equity Incentive Plans - Additional Information (Details)
Equity Incentive Plans - Summary of Stock-based Compensation Expense (Details)
Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)
Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Details)
Income Taxes - Additional Information (Details)
Subsequent events - Additional Information (Details)
All Reports